Other top stories

The Weekly Mind Reader: Antihypertensive Drugs and PTSD

August 4, 2023

Alzheimer's Drug Leqembi Offers Hope With a $5B Yearly Price Tag

August 3, 2023

FDA Approves Fast-Acting Postpartum Depression Pill

August 2, 2023

Experts Clash Over Serotonin's Role in Depression

August 1, 2023

Why 30% of Americans Experience 'Menu Anxiety'

July 31, 2023

The Weekly Mind Reader: Nurse-Lead CBT Delivered Online Shows Benefit for Postpartum Depression

July 28, 2023

Other stories

How 'Sleep Spindles' May Help Regulate Anxiety in PTSD

July 27, 2023

Reflecting on Triple Board Intern Year: Dr. Russell Ledet Says, "I Just Need You to See Me For Me"

July 26, 2023

Study Finds 25% of Emergency Room Visits by Older Adults Attributed to Dementia

July 25, 2023

Study: Long COVID Associated With Substantial Brain Fog

July 24, 2023

The Weekly Mind Reader: Ear Abnormalities and Depression

July 21, 2023

5 Minute Pearls: Essential Components for Optimizing Engagement with Patients with Major Depressive Disorder

July 20, 2023

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe